Arreskov, Anne Beiter http://orcid.org/0000-0001-5097-7563
Olsen, Maria Å.
Pouplier, Sandra Sinius
Siersma, Volkert
Andersen, Christen L.
Friis, Søren
de Fine Olivarius, Niels
Article History
Received: 7 September 2018
Accepted: 30 April 2019
First Online: 11 June 2019
Ethics approval and consent to participate
: The DCGP study was an open, cluster-randomized, controlled trial of the effect of intensified diabetes management. Taking written information about the study as a starting point, all patients gave verbal informed consent to participate, following a dialogue with their GP, where the patients could ask questions. When the study started in 1988, it was generally accepted to seek oral informed consent only, and this procedure was approved by The Copenhagen and Frederiksberg Research Ethics Committee (ExternalRef removed NCT01074762). The study was performed in accordance with the Helsinki Declaration. The study adheres to CONSORT guidelines.
: Not applicable.
: The authors declare that they have no competing interests.